As weve written, the GLP-1 market is evolving with incredible speed, and this recent development will doubtless prompt others
Subject to regulatory rules and laws that differ in the public and private sectors, PBMs carry out what plan sponsors direct them to in terms of the products they actually cover for enrollees
Emerging research suggests GLP-1s may directly affect the skin by reducing collagen production, accelerating glycation (which stiffens and weakens collagen fibers), and diminishing hydration levels
Its also possible to reduce the chances of irritation by switching injection sites each week
Then theres the hair use case
In the DURATION-8 trial, dapagliflozin as monotherapy and in combination with EX-QW showed trends favoring improvements in LFC, glucose and lipid metabolism, and liver fibrosis scores at the end of the study, but no significant statistical differences were observed